Firas G Petros

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Clinical Evaluation

Top Venues

BJU international

Translational andrology and urology

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Srigita Madiraju, Firas G Petros
Avelumab first-line maintenance for advanced or metastatic urothelial carcinoma: analysis from JAVELIN Bladder 100 trial. Translational andrology and urology 13 (7) (2024)
Srigita Madiraju, Firas G Petros
Avelumab first-line maintenance for advanced or metastatic urothelial carcinoma: analysis from JAVELIN Bladder 100 trial. Translational andrology and urology 13 (7) (2024)
Jennifer E Ten Eyck, Navkirat Kahlon, Sonia Masih, Danae M Hamouda, Firas G Petros
Clinical Evaluation of Avelumab in the Treatment of Advanced Urothelial Carcinoma: Focus on Patient Selection and Outcomes. Cancer management and research 14 (2022)
David d'Andrea, Surena F Matin, Peter C Black, Firas G Petros, Homayoun Zargar, Colin P Dinney, Michael S Cookson, Wassim Kassouf, Marc A Dall'Era, John S McGrath, Jonathan L Wright, Andrew C Thorpe, Todd M Morgan, Jeffrey M Holzbeierlein, Trinity J Bivalacqua, Srikala S Sridhar, Scott North, Daniel A Barocas, Yair Lotan, Andrew J Stephenson, Bas W van Rhijn, Philippe E Spiess, Siamak Daneshmand, Shahrokh F Shariat
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma. BJU international 127 (5) (2020)
Firas G Petros, Aradhana M Venkatesan, Diana Kaya, Chaan S Ng, Bryan M Fellman, Jose A Karam, Christopher G Wood, Surena F Matin
Conditional survival of patients with small renal masses undergoing active surveillance. BJU international 123 (3) (2018)
Firas G Petros, Christopher J D Wallis
The utility of microRNAs as biomarkers in predicting progression and survival in patients with clear-cell renal cell carcinoma. BJU international 120 (3) (2018)